187 related articles for article (PubMed ID: 28614794)
1. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.
Forcade E; Paz K; Flynn R; Griesenauer B; Amet T; Li W; Liu L; Bakoyannis G; Jiang D; Chu HW; Lobera M; Yang J; Wilkes DS; Du J; Gartlan K; Hill GR; MacDonald KP; Espada EL; Blanco P; Serody JS; Koreth J; Cutler CS; Antin JH; Soiffer RJ; Ritz J; Paczesny S; Blazar BR
JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614794
[TBL] [Abstract][Full Text] [Related]
2. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
Wu Y; Schutt S; Paz K; Zhang M; Flynn RP; Bastian D; Sofi MH; Nguyen H; Dai M; Liu C; Chang YJ; Blazar BR; Yu XZ
Blood; 2018 Apr; 131(17):1974-1986. PubMed ID: 29530952
[TBL] [Abstract][Full Text] [Related]
4. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
[TBL] [Abstract][Full Text] [Related]
5. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Tannheimer S; Johnson AJ; Dong S; Stark AK; Okkenhaug K; Panoskaltsis-Mortari A; Sage PT; Sharpe AH; Luznik L; Ritz J; Soiffer RJ; Cutler CS; Koreth J; Antin JH; Miklos DB; MacDonald KP; Hill GR; Maillard I; Serody JS; Murphy WJ; Munn DH; Feser C; Zaiken M; Vanhaesebroeck B; Turka LA; Byrd JC; Blazar BR
Am J Transplant; 2019 Jun; 19(6):1820-1830. PubMed ID: 30748099
[TBL] [Abstract][Full Text] [Related]
6. IL-Y Aggravates Murine Chronic Graft-
Wan L; Jin Z; Hu B; Lv K; Lei L; Liu Y; Song Y; Zhu Y; Gong H; Xu M; Du Y; Xu Y; Liu H; Wu D; Liu Y
Front Immunol; 2020; 11():559740. PubMed ID: 33329519
[TBL] [Abstract][Full Text] [Related]
7. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.
Flynn R; Paz K; Du J; Reichenbach DK; Taylor PA; Panoskaltsis-Mortari A; Vulic A; Luznik L; MacDonald KK; Hill GR; Nyuydzefe MS; Weiss JM; Chen W; Trzeciak A; Serody JS; Aguilar EG; Murphy WJ; Maillard I; Munn D; Koreth J; Cutler CS; Antin JH; Ritz J; Waksal SD; Zanin-Zhorov A; Blazar BR
Blood; 2016 Apr; 127(17):2144-54. PubMed ID: 26983850
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.
Li W; Liu L; Gomez A; Zhang J; Ramadan A; Zhang Q; Choi SW; Zhang P; Greenson JK; Liu C; Jiang D; Virts E; Kelich SL; Chu HW; Flynn R; Blazar BR; Hanenberg H; Hanash S; Paczesny S
JCI Insight; 2016 May; 1(6):. PubMed ID: 27195312
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease.
Thangavelu G; Zaiken MC; Mohamed FA; Flynn R; Du J; Rhee SY; Riddle MJ; Aguilar EG; Panoskaltsis-Mortari A; Sanders ME; Blazar BR
Front Immunol; 2022; 13():765319. PubMed ID: 35359939
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.
Schutt SD; Wu Y; Tang CH; Bastian D; Nguyen H; Sofi MH; Zhang M; Liu C; Helke K; Wilson C; Schnapp LM; Del Valle JR; Hu CC; Yu XZ
Blood Adv; 2018 Feb; 2(4):414-427. PubMed ID: 29483082
[TBL] [Abstract][Full Text] [Related]
11. Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.
Zhang M; Wu Y; Bastian D; Iamsawat S; Chang J; Daenthanasanmak A; Nguyen HD; Schutt S; Dai M; Chen F; Suh WK; Yu XZ
Front Immunol; 2018; 9():1461. PubMed ID: 29988391
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.
Du J; Paz K; Flynn R; Vulic A; Robinson TM; Lineburg KE; Alexander KA; Meng J; Roy S; Panoskaltsis-Mortari A; Loschi M; Hill GR; Serody JS; Maillard I; Miklos D; Koreth J; Cutler CS; Antin JH; Ritz J; MacDonald KP; Schacker TW; Luznik L; Blazar BR
Blood; 2017 May; 129(18):2570-2580. PubMed ID: 28254742
[TBL] [Abstract][Full Text] [Related]
13. Targeting Inflammatory T Helper Cells
Buchele V; Abendroth B; Büttner-Herold M; Vogler T; Rothamer J; Ghimire S; Ullrich E; Holler E; Neurath MF; Hildner K
Front Immunol; 2018; 9():1138. PubMed ID: 29910804
[TBL] [Abstract][Full Text] [Related]
14. Blockade of PD-1/PD-L1 increases effector T cells and aggravates murine chronic graft-versus-host disease.
Liang Y; Shen J; Lan Q; Zhang K; Xu Y; Duah M; Xu K; Pan B
Int Immunopharmacol; 2022 Sep; 110():109051. PubMed ID: 35850051
[TBL] [Abstract][Full Text] [Related]
15. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.
Kolupaev OV; Dant TA; Bommiasamy H; Bruce DW; Fowler KA; Tilley SL; McKinnon KP; Sarantopoulos S; Blazar BR; Coghill JM; Serody JS
Blood Adv; 2018 Sep; 2(18):2307-2319. PubMed ID: 30228128
[TBL] [Abstract][Full Text] [Related]
17. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Srinivasan M; Flynn R; Price A; Ranger A; Browning JL; Taylor PA; Ritz J; Antin JH; Murphy WJ; Luznik L; Shlomchik MJ; Panoskaltsis-Mortari A; Blazar BR
Blood; 2012 Feb; 119(6):1570-80. PubMed ID: 22072556
[TBL] [Abstract][Full Text] [Related]
18. ICOSL
Adom D; Dillon SR; Yang J; Liu H; Ramadan A; Kushekhar K; Hund S; Albright A; Kirksey M; Adeniyan T; Lewis KE; Evans L; Wu R; Levin SD; Mudri S; Yang J; Rickel E; Seaberg M; Henderson K; Gudgeon CJ; Wolfson MF; Swanson RM; Swiderek KM; Peng SL; Hippen KL; Blazar BR; Paczesny S
Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028709
[TBL] [Abstract][Full Text] [Related]
19. Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.
Jin H; Ni X; Deng R; Song Q; Young J; Cassady K; Zhang M; Forman S; Martin PJ; Liu Q; Zeng D
Blood; 2016 May; 127(18):2249-60. PubMed ID: 26884373
[TBL] [Abstract][Full Text] [Related]
20. IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity.
Lv K; Hu B; Xu M; Wan L; Jin Z; Xu M; Du Y; Ma K; Lv Q; Xu Y; Lei L; Gong H; Liu H; Wu D; Liu Y
Exp Hematol Oncol; 2022 Jun; 11(1):34. PubMed ID: 35655245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
